The Cholangiocarcinoma Foundation (CCF) is pleased to announce the 11th Annual Cholangiocarcinoma Foundation Conference in Salt Lake City, UT, April 17-19, 2024. The 3-day event includes a special patient and caregiver day and 2+ days of scientific sessions.
One of the most unique and fulfilling parts of the annual conference is the interaction between the research community, providers, patients, and caregivers, and we know this year will provide even more meaningful collaboration. Please go to https://cholangiocarcinoma.org/2024-annual-conference/ to register, and we look forward to seeing you in April.
Basic Science Track
Wednesday is dedicated to patients and caregivers, and the day also offers a new basic science track for researchers and providers. Join us for a patient-friendly update on CCF’s programs, hear from patients and caregivers who are dealing with cholangiocarcinoma (CCA), and learn how you can get involved and help make a difference. Plus join us for some fun and wear green in support of all CCA patients.
Thursday is geared toward the scientific and medical community. Renowned experts in the field will present the latest advances in research, clinical advancements, and treatment options. Attendees will have the opportunity to engage with our speakers through live Q&A sessions, interactive breakout sessions, and networking events.
Continuing the scientific focus, Friday offers more in-depth insights into the latest developments in CCA research and treatment. Explore breakthroughs, case studies, and emerging therapies contributing to our collective knowledge and progress in combating this disease.
“The conference brings together a multidisciplinary group of experts from around the world to present and exchange scientific ideas and proposals relating to the complex landscape of CCA. Global collaboration and high-quality research are hallmarks of the conference,” said Foundation CEO and Founder Stacie C. Lindsey. “A scientific conference that gives patients a seat at the table is the kind of inclusive, collaborative effort that makes this community unique. We are looking forward to a great conference.”
CCF is the leading global resource for CCA, a rare but deadly bile duct cancer. It strives to improve methods for early detection, advance treatment options, and improve quality of life and survival for CCA patients. The conference is the premier source for the presentation of research, innovative therapies, and patient education. In 2023, more than 1000 attendees participated in the conference.
Distinguished cochairs of the conference are Angela Lamarca, MD, PhD, MSc, Medical Oncology, Fundación Jiménez Diaz University Hospital; Mitesh J. Borad, MD, Program Leader—Gene and Virus Therapy Program, Mayo Clinic; and Do-Youn Oh, MD, PhD, Seoul National University Hospital. They are also among the more than 50 speakers who are presenting in designated sessions throughout the conference, which focuses on basic, translational, and clinical research.
In addition, the Foundation is honoring 3 individuals with its distinguished Mark R. Clements Award for volunteerism, community impact and vision, innovation, and collaboration. Mark R. Clements is the brainchild of the Foundation. He passed away from the disease in January 2006. His sister, Stacie C. Lindsey, and other family members carried out Mark’s wishes and founded the 501(c)(3) that is now moving into its 18th year in existence.
“The Mark R. Clements Awards are the highest honor awarded by the Foundation each year. As a CCA patient himself, Mark Clements was truly the inspiration and driving force around the creation of this Foundation,” said Lindsey.
A recent study estimates that by 2040, liver and bile duct cancer will be the third deadliest cancer in the United States.1 To advocate for much-needed funding and promote education about the disease, the Foundation hosts an Annual Conference each year to unite people who are fearlessly working to find a cure for CCA and share the latest education for CCA patients, caregivers, and professionals.
To sign up for our newsletter or print publications, please enter your contact information below.
